Aristolochic acid nephropathy: a worldwide problem (Q34590610)

3 August 2017

1 reference

title

Aristolochic acid nephropathy: a worldwide problem (English)

1 reference

3 August 2017

1 reference

Frédéric D Debelle

1

1 reference

3 August 2017

Jean-Louis Vanherweghem

series ordinal

2

1 reference

3 August 2017

Joëlle L Nortier

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

16 April 2008

1 reference

3 August 2017

1 reference

3 August 2017

74

1 reference

3 August 2017

158-169

1 reference

3 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2008.129

3 August 2017

0 references

cites work

Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Identification of aristolochic acid in Chinese herbs.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Urothelial malignancy in nephropathy due to Chinese herbs

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Complexities of the herbal nomenclature system in traditional Chinese medicine (TCM): lessons learned from the misuse of Aristolochia-related species and the importance of the pharmaceutical name during botanical drug product development.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Rapidly progressive interstitial renal fibrosis due to a chronic intake of a herb (Aristolochia pistolochia) infusion.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Nephropathy caused by Chinese herbs in the UK

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Chinese herb nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Reversible Fanconi syndrome after ingestion of a Chinese herbal 'remedy' containing aristolochic acid

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Aristolochic acid as a causative factor in a case of Chinese herbal nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Fanconi's syndrome and subsequent progressive renal failure caused by a Chinese herb containing aristolochic acid

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Aristolochic acid nephropathy complicating a patient with focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Chinese herbal uropathy and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Possible mechanisms explaining the tendency towards interstitial fibrosis in aristolochic acid-induced acute tubular necrosis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Aristolochic Acid Nephropathy: The Hong Kong Perspective

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Aristolochic acid and the etiology of endemic (Balkan) nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Hong Kong samples of the traditional Chinese medicine “Fang Ji” contain aristolochic acid toxins

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Quantitative analysis of aristolochic acids, toxic compounds, contained in some medicinal plants

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Aristolochia sp and chronic interstitial nephropathies in Indians.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Etiology of Balkan Endemic Nephropathy and Associated Urothelial Cancer

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Aristolochic Acid, an Herbal Carcinogen, Sold on the Web after FDA Alert

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Chinese herbs nephropathy: a clue to Balkan endemic nephropathy?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Detection of Herba Aristolochia Mollissemae in a patient with unexplained nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Outbreak of Chinese herb nephropathy in Japan: are there any differences from Belgium?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

An unusual cause of hypokalemic paralysis: aristolochic acid nephropathy with Fanconi syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Aristolochic acid-induced Fanconi's syndrome and nephropathy presenting as hypokalemic paralysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Aristolochic acid as a probable human cancer hazard in herbal remedies: a review.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Chinese herbs nephropathy presentation, natural history and fate after transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Low molecular weight proteinuria in Chinese herbs nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Proximal tubular injury in Chinese herbs nephropathy: monitoring by neutral endopeptidase enzymuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study in Chinese herbs nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Steroid therapy in chronic interstitial renal fibrosis: the case of Chinese-herb nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

On a nephrotoxic and carcinogenic slimming regimen

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Role of serotonin in the development of Chinese herbs nephropathy?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Effects of dexfenfluramine on aristolochic acid nephrotoxicity in a rat model for Chinese-herb nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Association of valvular heart disease with Chinese-herb nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

High prevalence of fenfluramine-related aortic regurgitation in women with end-stage renal disease secondary to Chinese herb nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

For patients taking herbal therapy--lessons from aristolochic acid nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Determination of aristolochic acid in Chinese herbal medicine by capillary electrophoresis with laser-induced fluorescence detection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Chronic renal failure in India

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Urothelial lesions in Chinese-herb nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Urothelial malignant disease and Chinese herbal nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Study of the phase I and phase II metabolism of nephrotoxin aristolochic acid by liquid chromatography/tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Studies on the metabolism of aristolochic acids I and II.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Using polymerase arrest to detect DNA binding specificity of aristolochic acid in the mouse H-ras gene

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

On the histopathogenesis of rat forestomach carcinoma caused by aristolochic acid

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Tumour induction in mice following exposure to aristolochic acid

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Acute toxicity of aristolochic acid in rodents

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Transgene-derived hepatocyte growth factor attenuates reactive renal fibrosis in aristolochic acid nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

The renin-angiotensin system blockade does not prevent renal interstitial fibrosis induced by aristolochic acids

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Acute nephrotoxicity of aristolochic acids in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Chinese herbs nephropathy-associated slimming regimen induces tumours in the forestomach but no interstitial nephropathy in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Structure activity relationships of aristolochic acid analogues: toxicity in cultured renal epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Selective toxicity of aristolochic acids I and II.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Early proximal tubule injury in experimental aristolochic acid nephropathy: functional and histological studies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

The nephrotoxicity of Aristolochia manshuriensis in rats is attributable to its aristolochic acids

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Effect of aristolochic acid on intracellular calcium concentration and its links with apoptosis in renal tubular cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Critical evaluation of environmental exposure agents suspected in the etiology of Balkan endemic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

DNA ploidy distribution in renal tumours induced in male rats by dietary ochratoxin A

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Ochratoxin A as a potential etiologic factor in endemic nephropathy: lessons from toxicity studies in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Perspective: ochratoxin A is not a genotoxic carcinogen

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Further studies with a cell immortalization assay to investigate the mutation signature of aristolochic acid in human p53 sequences

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Role of environmental toxins in endemic (Balkan) nephropathy. October 2006, Zagreb, Croatia.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.129

7 January 2021

Identifiers

DOI

10.1038/KI.2008.129

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference